Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[We found ERBB4 mutations in 19% of individuals with melanoma and found mutations in two other kinases (FLT1 and PTK2B) in 10% of individuals with melanomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP27886.RAwwdY-8rPZ4IeI6SQ8Ko7U8Aofa3pqfWCxvuN9FeJVAY130_assertion description "[We found ERBB4 mutations in 19% of individuals with melanoma and found mutations in two other kinases (FLT1 and PTK2B) in 10% of individuals with melanomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP27886.RAwwdY-8rPZ4IeI6SQ8Ko7U8Aofa3pqfWCxvuN9FeJVAY130_provenance.
• NP246980.RANUlDBDm5-FKdsyO43JwjaUNaT3G5IYyNtGf1XICgM2M130_assertion description "[We found ERBB4 mutations in 19% of individuals with melanoma and found mutations in two other kinases (FLT1 and PTK2B) in 10% of individuals with melanomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP246980.RANUlDBDm5-FKdsyO43JwjaUNaT3G5IYyNtGf1XICgM2M130_provenance.
• NP14993.RA_QroyWedlOPRd1gl-T0prhtQNd2HISain-Sss3q-7ms130_assertion description "[We found ERBB4 mutations in 19% of individuals with melanoma and found mutations in two other kinases (FLT1 and PTK2B) in 10% of individuals with melanomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP14993.RA_QroyWedlOPRd1gl-T0prhtQNd2HISain-Sss3q-7ms130_provenance.
• NP27887.RAp-q_wTPQl7_ANXYQzkPOuHiG7TnD3tEIivwXAo9XDbQ130_assertion description "[We found ERBB4 mutations in 19% of individuals with melanoma and found mutations in two other kinases (FLT1 and PTK2B) in 10% of individuals with melanomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP27887.RAp-q_wTPQl7_ANXYQzkPOuHiG7TnD3tEIivwXAo9XDbQ130_provenance.
• NP15961.RAfWMXBWDwUNSv3wvJxGrwgEvuoaWUBUysKFp7_LZdew8130_assertion description "[We found ERBB4 mutations in 19% of individuals with melanoma and found mutations in two other kinases (FLT1 and PTK2B) in 10% of individuals with melanomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP15961.RAfWMXBWDwUNSv3wvJxGrwgEvuoaWUBUysKFp7_LZdew8130_provenance.
• assertion description "[We found ERBB4 mutations in 19% of individuals with melanoma and found mutations in two other kinases (FLT1 and PTK2B) in 10% of individuals with melanomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We found ERBB4 mutations in 19% of individuals with melanoma and found mutations in two other kinases (FLT1 and PTK2B) in 10% of individuals with melanomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We found ERBB4 mutations in 19% of individuals with melanoma and found mutations in two other kinases (FLT1 and PTK2B) in 10% of individuals with melanomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP626336.RA6e2BKpGqkey3xr1vI1cSUBTxJwVUqGgWXiEeL4snaVc130_assertion description "[We found ERBB4 mutations in 19% of individuals with melanoma and found mutations in two other kinases (FLT1 and PTK2B) in 10% of individuals with melanomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP626336.RA6e2BKpGqkey3xr1vI1cSUBTxJwVUqGgWXiEeL4snaVc130_provenance.
• assertion description "[We found ERBB4 mutations in 19% of individuals with melanoma and found mutations in two other kinases (FLT1 and PTK2B) in 10% of individuals with melanomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We found ERBB4 mutations in 19% of individuals with melanoma and found mutations in two other kinases (FLT1 and PTK2B) in 10% of individuals with melanomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We found ERBB4 mutations in 19% of individuals with melanoma and found mutations in two other kinases (FLT1 and PTK2B) in 10% of individuals with melanomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP87497.RAceGoImc_FHxkz1VVe0iCAbOHfD8VAFDizhIfm3Ob3j8130_assertion description "[We found ERBB4 mutations in 19% of individuals with melanoma and found mutations in two other kinases (FLT1 and PTK2B) in 10% of individuals with melanomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP87497.RAceGoImc_FHxkz1VVe0iCAbOHfD8VAFDizhIfm3Ob3j8130_provenance.
• NP107268.RAQeoftUlUKjxrUQGqXJElMPGFtIhvPgQKsCuxw3HMrwo130_assertion description "[We found ERBB4 mutations in 19% of individuals with melanoma and found mutations in two other kinases (FLT1 and PTK2B) in 10% of individuals with melanomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP107268.RAQeoftUlUKjxrUQGqXJElMPGFtIhvPgQKsCuxw3HMrwo130_provenance.
• NP14921.RARQRb2epWuTXjfJKvmsIvNhWZ9qQ23hu809btRbWkM6Y130_assertion description "[We found ERBB4 mutations in 19% of individuals with melanoma and found mutations in two other kinases (FLT1 and PTK2B) in 10% of individuals with melanomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP14921.RARQRb2epWuTXjfJKvmsIvNhWZ9qQ23hu809btRbWkM6Y130_provenance.
• NP789262.RA-Yb9JNZGNqOnLvJMkdPIXMO-bPPP9bjcPmXXvRdnzeM130_assertion description "[We found ERBB4 mutations in 19% of individuals with melanoma and found mutations in two other kinases (FLT1 and PTK2B) in 10% of individuals with melanomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP789262.RA-Yb9JNZGNqOnLvJMkdPIXMO-bPPP9bjcPmXXvRdnzeM130_provenance.
• NP27860.RA5ieSUnhM6MXucd9DPX2D3w4FtIAQmYW_lYEtO8A24gk130_assertion description "[We found ERBB4 mutations in 19% of individuals with melanoma and found mutations in two other kinases (FLT1 and PTK2B) in 10% of individuals with melanomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP27860.RA5ieSUnhM6MXucd9DPX2D3w4FtIAQmYW_lYEtO8A24gk130_provenance.
• NP155607.RAQYZEF2rQLMd-XFis2CLdaSGCBsUDIX8mf1U_XWl-K98130_assertion description "[We found ERBB4 mutations in 19% of individuals with melanoma and found mutations in two other kinases (FLT1 and PTK2B) in 10% of individuals with melanomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP155607.RAQYZEF2rQLMd-XFis2CLdaSGCBsUDIX8mf1U_XWl-K98130_provenance.
• NP155608.RAX9NB0g6btPDB5q4bkbZuq49xFgTzFs-qzbMdmZ6QKSA130_assertion description "[We found ERBB4 mutations in 19% of individuals with melanoma and found mutations in two other kinases (FLT1 and PTK2B) in 10% of individuals with melanomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP155608.RAX9NB0g6btPDB5q4bkbZuq49xFgTzFs-qzbMdmZ6QKSA130_provenance.
• NP393989.RAvIVan5qu9UNb2BRcOyQpkg5eE6PLg8vJMIP28FUbtWU130_assertion description "[We found ERBB4 mutations in 19% of individuals with melanoma and found mutations in two other kinases (FLT1 and PTK2B) in 10% of individuals with melanomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP393989.RAvIVan5qu9UNb2BRcOyQpkg5eE6PLg8vJMIP28FUbtWU130_provenance.
• NP407548.RAIqGuKfaXP78kWKiZy7Nsw0Viz24Rbj-fjLwmgpsT6Gc130_assertion description "[We found ERBB4 mutations in 19% of individuals with melanoma and found mutations in two other kinases (FLT1 and PTK2B) in 10% of individuals with melanomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP407548.RAIqGuKfaXP78kWKiZy7Nsw0Viz24Rbj-fjLwmgpsT6Gc130_provenance.
• NP760271.RAKXUcXiZJ_Ii3WxhF8IWO6ZVO1lMT7KuRrgeAsTpMERk130_assertion description "[We found ERBB4 mutations in 19% of individuals with melanoma and found mutations in two other kinases (FLT1 and PTK2B) in 10% of individuals with melanomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP760271.RAKXUcXiZJ_Ii3WxhF8IWO6ZVO1lMT7KuRrgeAsTpMERk130_provenance.
• NP760274.RAxGRQbgnPqfj0x1cVRE1iGU9xKpDtVhcC2qm3Y22QP3I130_assertion description "[We found ERBB4 mutations in 19% of individuals with melanoma and found mutations in two other kinases (FLT1 and PTK2B) in 10% of individuals with melanomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP760274.RAxGRQbgnPqfj0x1cVRE1iGU9xKpDtVhcC2qm3Y22QP3I130_provenance.